18F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?

被引:28
作者
Barrington, Sally F. [1 ,2 ]
Johnson, Peter W. M. [3 ]
机构
[1] Kings Coll London, London SE1 7EH, England
[2] Kings Coll London, Guys & St Thomas PET Ctr, Div Imaging Sci & Biomed Engn, London, England
[3] Univ Southampton, Canc Res UK Ctr, Southampton, England
基金
英国工程与自然科学研究理事会;
关键词
positron emission tomography; lymphoma; precision medicine; POSITRON-EMISSION-TOMOGRAPHY; STAGE HODGKINS LYMPHOMA; RESPONSE-ADAPTED THERAPY; B-CELL LYMPHOMA; INTERIM PET; OPEN-LABEL; PHASE-II; TRIAL; CRITERIA; CT;
D O I
10.2967/jnumed.116.181347
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
100231 [临床病理学]; 100902 [航空航天医学];
摘要
PET/CT using F-18-FDG is an essential part of the management of patients with lymphoma. Efforts to standardize PET acquisition and reporting, including the 5-point Deauville scale, have enabled PET to become a surrogate for treatment success or failure in common lymphoma subtypes. This review summarizes the key clinical-trial evidence that supports PET-directed personalized approaches in lymphoma. PET-guided therapy has improved outcomes in Hodgkin lymphoma, using less chemotherapy and more selective radiotherapy. Attempts to intensify chemotherapy in aggressive non-Hodgkin lymphomas have, however, proved ineffective in patients treated with rituximab and chemotherapy. Trials are under way to determine whether PET can obviate consolidation radiotherapy in patients with diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma. More recently, PET has been reported to be a reliable predictor of outcome in follicular lymphoma requiring treatment, and prospective trials to test PET-guided therapy in this disease are anticipated.
引用
收藏
页码:1539 / 1544
页数:6
相关论文
共 30 条
[1]
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial [J].
Andre, Marc P. E. ;
Girinsky, Theodore ;
Federico, Massimo ;
Reman, Oumedaly ;
Fortpied, Catherine ;
Gotti, Manuel ;
Casasnovas, Olivier ;
Brice, Pauline ;
van der Maazen, Richard ;
Re, Alessandro ;
Edeline, Veronique ;
Ferme, Christophe ;
van Imhoff, Gustaaf ;
Merli, Francesco ;
Bouabdallah, Reda ;
Sebban, Catherine ;
Specht, Lena ;
Stamatoullas, Aspasia ;
Delarue, Richard ;
Fiaccadori, Valeria ;
Bellei, Monica ;
Raveloarivahy, Tiana ;
Versari, Annibale ;
Hutchings, Martin ;
Meignan, Michel ;
Raemaekers, John .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (16) :1786-+
[2]
[Anonymous], 2015, BLOOD, DOI [DOI 10.1182/BLOOD.V126.23.577.577, 10.1182/blood.V126.23.577.577]
[3]
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Lesokhin, Alexander M. ;
Borrello, Ivan ;
Halwani, Ahmad ;
Scott, Emma C. ;
Gutierrez, Martin ;
Schuster, Stephen J. ;
Millenson, Michael M. ;
Cattry, Deepika ;
Freeman, Gordon J. ;
Rodig, Scott J. ;
Chapuy, Bjoern ;
Ligon, Azra H. ;
Zhu, Lili ;
Grosso, Joseph F. ;
Kim, Su Young ;
Timmerman, John M. ;
Shipp, Margaret A. ;
Armand, Philippe .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319
[4]
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study [J].
Barrington, Sally F. ;
Kirkwood, Amy A. ;
Franceschetto, Antonella ;
Fulham, Michael J. ;
Roberts, Thomas H. ;
Almquist, Helen ;
Brun, Eva ;
Hjorthaug, Karin ;
Viney, Zaid N. ;
Pike, Lucy C. ;
Federico, Massimo ;
Luminari, Stefano ;
Radford, John ;
Trotman, Judith ;
Fossa, Alexander ;
Berkahn, Leanne ;
Molin, Daniel ;
D'Amore, Francesco ;
Sinclair, Donald A. ;
Smith, Paul ;
O'Doherty, Michael J. ;
Stevens, Lindsey ;
Johnson, Peter W. .
BLOOD, 2016, 127 (12) :1531-1538
[5]
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].
Barrington, Sally F. ;
Mikhaeel, N. George ;
Kostakoglu, Lale ;
Meignan, Michel ;
Hutchings, Martin ;
Mueeller, Stefan P. ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Fisher, Richard I. ;
Trotman, Judith ;
Hoekstra, Otto S. ;
Hicks, Rodney J. ;
O'Doherty, Michael J. ;
Hustinx, Roland ;
Biggi, Alberto ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+
[6]
International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers [J].
Biggi, Alberto ;
Gallamini, Andrea ;
Chauvie, Stephane ;
Hutchings, Martin ;
Kostakoglu, Lale ;
Gregianin, Michele ;
Meignan, Michel ;
Malkowski, Bogdan ;
Hofman, Michael S. ;
Barrington, Sally F. .
JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (05) :683-690
[7]
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 [J].
Boellaard, Ronald ;
Delgado-Bolton, Roberto ;
Oyen, Wim J. G. ;
Giammarile, Francesco ;
Tatsch, Klaus ;
Eschner, Wolfgang ;
Verzijlbergen, Fred J. ;
Barrington, Sally F. ;
Pike, Lucy C. ;
Weber, Wolfgang A. ;
Stroobants, Sigrid ;
Delbeke, Dominique ;
Donohoe, Kevin J. ;
Holbrook, Scott ;
Graham, Michael M. ;
Testanera, Giorgio ;
Hoekstra, Otto S. ;
Zijlstra, Josee ;
Visser, Eric ;
Hoekstra, Corneline J. ;
Pruim, Jan ;
Willemsen, Antoon ;
Arends, Bertjan ;
Kotzerke, Joerg ;
Bockisch, Andreas ;
Beyer, Thomas ;
Chiti, Arturo ;
Krause, Bernd J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) :328-354
[8]
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group [J].
Borchmann, Peter ;
Haverkamp, Heinz ;
Lohri, Andreas ;
Mey, Ulrich ;
Kreissl, Stefanie ;
Greil, Richard ;
Markova, Jana ;
Feuring-Buske, Michaela ;
Meissner, Julia ;
Duehrsen, Ulrich ;
Ostermann, Helmut ;
Keller, Ulrich ;
Maschmeyer, Georg ;
Kuhnert, Georg ;
Dietlein, Markus ;
Kobe, Carsten ;
Eich, Hans ;
Baues, Christian ;
Stein, Harald ;
Fuchs, Michael ;
Diehl, Volker ;
Engert, Andreas .
LANCET ONCOLOGY, 2017, 18 (04) :454-463
[9]
Speed bumps on the road to a chemotherapy-free world for lymphoma patients [J].
Cheson, Bruce D. .
BLOOD, 2016, 128 (03) :325-330
[10]
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].
Cheson, Bruce D. ;
Fisher, Richard I. ;
Barrington, Sally F. ;
Cavalli, Franco ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Lister, T. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+